These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 8215837

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer.
    Elledge RM, Clark GM, Fuqua SA, Yu YY, Allred DC.
    Cancer Res; 1994 Jul 15; 54(14):3752-7. PubMed ID: 8033095
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cysteine proteinase inhibitor cystatin A in breast cancer.
    Kuopio T, Kankaanranta A, Jalava P, Kronqvist P, Kotkansalo T, Weber E, Collan Y.
    Cancer Res; 1998 Feb 01; 58(3):432-6. PubMed ID: 9458085
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
    Turner BC, Gumbs AA, Carbone CJ, Carter D, Glazer PM, Haffty BG.
    Cancer; 2000 Mar 01; 88(5):1091-8. PubMed ID: 10699900
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma.
    Visscher DW, Sarkar F, Tabaczka P, Crissman J.
    Mod Pathol; 1996 Jun 01; 9(6):642-6. PubMed ID: 8782201
    [Abstract] [Full Text] [Related]

  • 8. Studies on p53 immunolocalisation in breast cancer and its prognostic significance.
    Meenakshi A, Manoharan V.
    Hum Antibodies; 1999 Jun 01; 9(3):171-6. PubMed ID: 10690631
    [Abstract] [Full Text] [Related]

  • 9. p53 immunoreactivity in primary and metastatic prostatic adenocarcinoma.
    Hughes JH, Cohen MB, Robinson RA.
    Mod Pathol; 1995 Jun 01; 8(5):462-6. PubMed ID: 7675761
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immunohistochemical analysis of p53 and c-erbB-2 in breast cancer].
    Castiglioni T, Elsner B, Curutchet HP, Montesinos M, Debonis D.
    Medicina (B Aires); 1995 Jun 01; 55(5 Pt 1):415-20. PubMed ID: 8728771
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunohistochemical expression of p53 and c-erbB2 proteins in breast cancer in Egypt.
    el-A Helal T, Khalifa A, Kamel AS.
    Anticancer Res; 2000 Jun 01; 20(3B):2145-50. PubMed ID: 10928168
    [Abstract] [Full Text] [Related]

  • 15. Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer.
    Barbati A, Cosmi EV, Sidoni A, Collini P, Porpora MG, Ferri I, Lüthy M, Lauro V, Bucciarelli E.
    Anticancer Res; 1997 Jun 01; 17(1A):401-5. PubMed ID: 9066684
    [Abstract] [Full Text] [Related]

  • 16. The relationship between expression of p53/Bcl-2 and histopathological criteria in breast invasive ductal carcinomas.
    Gursan N, Karakök M, Sari I, Gursan MS.
    Int J Clin Pract; 2001 Nov 01; 55(9):589-90. PubMed ID: 11770353
    [Abstract] [Full Text] [Related]

  • 17. Prognostic relevance of p53 in node negative breast cancer.
    Kristen P, Müller JG, Caffier H.
    Anticancer Res; 1997 Nov 01; 17(4B):2869-71. PubMed ID: 9329550
    [Abstract] [Full Text] [Related]

  • 18. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.
    Wang X, Jones TD, Maclennan GT, Yang XJ, Lopez-Beltran A, Eble JN, Koch MO, Lin H, Baldridge LA, Tretiakova M, Cheng L.
    Anticancer Res; 2005 Nov 01; 25(3B):2001-4. PubMed ID: 16158936
    [Abstract] [Full Text] [Related]

  • 19. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
    Lopes A, Bezerra AL, Pinto CA, Serrano SV, de MellO CA, Villa LL.
    J Urol; 2002 Jul 01; 168(1):81-6. PubMed ID: 12050497
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
    Rudland PS, Platt-Higgins A, El-Tanani M, De Silva Rudland S, Barraclough R, Winstanley JH, Howitt R, West CR.
    Cancer Res; 2002 Jun 15; 62(12):3417-27. PubMed ID: 12067984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.